NPI: 1881977593 · ROXBORO, NC 27573 · General Acute Care Hospital · NPI assigned 09/20/2011
Authorized official LAWRENCE, CHARLOTTE controls 20+ related entities in our dataset. Read more
| Authorized Official | LAWRENCE, CHARLOTTE (SECRETARY) |
| NPI Enumeration Date | 09/20/2011 |
Other providers sharing the same authorized official: LAWRENCE, CHARLOTTE
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 20,532 | $602K |
| 2019 | 20,617 | $485K |
| 2020 | 11,306 | $316K |
| 2021 | 13,697 | $519K |
| 2022 | 14,567 | $683K |
| 2023 | 15,489 | $745K |
| 2024 | 16,072 | $781K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 12,618 | 10,444 | $1.18M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 10,111 | 8,190 | $1.15M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 6,262 | 4,914 | $891K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3,320 | 2,748 | $233K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 14,992 | 11,397 | $81K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 2,296 | 1,856 | $76K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 3,764 | 2,558 | $71K |
| 80053 | Comprehensive metabolic panel | 10,741 | 8,416 | $64K |
| 71045 | Radiologic examination, chest; single view | 2,259 | 1,746 | $47K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 3,029 | 1,822 | $44K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1,964 | 1,549 | $36K |
| 87400 | 2,716 | 2,321 | $33K | |
| 96361 | Intravenous infusion, hydration; each additional hour | 1,016 | 731 | $28K |
| 36415 | Collection of venous blood by venipuncture | 16,326 | 12,249 | $25K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 631 | 483 | $23K |
| G0378 | Hospital observation service, per hour | 108 | 76 | $21K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 614 | 239 | $17K |
| 96375 | Therapeutic injection; each additional sequential IV push | 589 | 436 | $14K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 703 | 524 | $11K |
| 84484 | 1,638 | 1,152 | $11K | |
| 83735 | 2,527 | 1,913 | $11K | |
| 83690 | 1,268 | 1,022 | $7K | |
| 81001 | 2,753 | 2,154 | $6K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 458 | 388 | $5K |
| 71046 | Radiologic examination, chest; 2 views | 210 | 182 | $5K |
| 81025 | 719 | 605 | $5K | |
| 81003 | 2,424 | 1,924 | $4K | |
| 82553 | 673 | 460 | $4K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 110 | 94 | $3K |
| 80048 | Basic metabolic panel (calcium, ionized) | 641 | 469 | $3K |
| 87081 | 441 | 385 | $2K | |
| 70450 | Computed tomography, head or brain; without contrast material | 18 | 13 | $2K |
| 0012A | 37 | 37 | $2K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 12 | 12 | $2K |
| 82550 | 630 | 440 | $2K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 50 | 39 | $2K |
| 83880 | 134 | 94 | $2K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 582 | 450 | $2K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 14 | 13 | $1K |
| 85730 | 523 | 365 | $1K | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 434 | 149 | $1K |
| 85610 | 710 | 495 | $1K | |
| 87430 | 99 | 88 | $1K | |
| 0011A | 36 | 36 | $1K | |
| J7030 | Infusion, normal saline solution , 1000 cc | 44 | 38 | $1K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 373 | 89 | $917.15 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 15 | 12 | $720.91 |
| 84100 | 252 | 229 | $660.01 | |
| 87807 | 45 | 40 | $562.91 | |
| 0064A | 13 | 12 | $355.15 | |
| J2704 | Injection, propofol, 10 mg | 46 | 38 | $287.76 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 46 | 41 | $154.08 |
| 83605 | 17 | 13 | $116.01 | |
| 80076 | 23 | 17 | $99.90 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 16 | 12 | $79.10 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 17 | 17 | $78.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 46 | 38 | $62.88 |
| 86140 | 19 | 14 | $51.41 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 34 | 33 | $36.89 |
| 84443 | Thyroid stimulating hormone (TSH) | 22 | 21 | $20.31 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 52 | 38 | $12.35 |